Drug-eluting stents are a dramatic technological advancement, which have been proven to significantly reduce the risk of restenosis among patients. These stents are lined with medication which inhibit the build up of plaque in the artery directly around the stent, allowing blood to flow. Penn Cardiac Care interventional cardiologists were among the few in the country to help develop these stents and participated in a study which evaluated their effectiveness. While the risk of restenosis with traditional stents is 20 percent, the study indicated that drug-eluting stents decrease the risk to just five percent, allowing patients to avoid additional interventions and maintain their lifestyle.India Interventional Cardiology, India Cardiology, India Cost Interventional Cardiology, India Interventional Cardiology, India Interventional Cardiology, India Radiation Effects, India Drug-Coated Stent, India Hospital & Clinics, India Medical Center, India Cardiology, India Coronary Artery Disease, India Hospitals, India Cardiology For Patients And Physicians, India Radiation Protection, India Cardiologists, India Fluoroscopy, India Surgery Tour, India Protection, India Patient, India Radiation Injuries, India Patient Exposure. Catheterization Laboratory, India Coronary Heart Disease, India Counterpulsation, India Peripheral Arterial Intervention, India CABG, India CAD, India Cardiac, India Cardiomyopathy